Synopsys, Inc. is a dominant provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify, and manufacture integrated circuits and complex systems-on-chip (SoCs). Its tools enable chipmakers to simulate, synthesize, and validate increasingly complex architectures before production begins. The company occupies a near-duopoly position in EDA alongside Cadence Design Systems, with deep integration into customer workflows that create substantial switching costs. The completed $35 billion acquisition of Ansys in late 2024 expanded Synopsys' reach into multiphysics simulation spanning structural, fluid, thermal, and electromagnetic analysis, broadening its addressable market well beyond chip design into automotive, aerospace, and industrial applications. With a market capitalization of approximately $71.5 billion and institutional ownership exceeding 85%, Synopsys is closely watched by investors as a bellwether for semiconductor R&D spending and AI infrastructure demand.
Over the last 30 calendar days, SNPS declined from a closing price of $454.34 on June 26 to $373.47 on July 24, representing a decline of approximately 17.8%. The descent was not gradual; the stock experienced an accelerating selloff through mid-July, punctuated by a 7.9% single-day plunge on July 17 when shares dropped from $417.03 to $384.24. By late July, SNPS was trading roughly 41% below its 52-week high of $651.73 reached in July 2025, with the Relative Strength Index falling to deeply oversold territory near 22.5.
The quarterly picture is similarly stark. From trading around the $495–$500 range in late May following the company's fiscal Q2 earnings release, the stock has steadily deteriorated. The 50-day moving average sits at approximately $456, while the 200-day moving average hovers near $455 — both significantly above the current trading price, indicating sustained technical weakness. The stock's trajectory over the quarter reflects a market that has progressively repriced Synopsys as integration costs, margin concerns, and strategic repositioning have weighed on investor conviction.
Multiple catalysts converged to drive Synopsys lower over the past month. The most significant originated with the company's fiscal Q2 2026 earnings report on May 27, where revenue of $2.28 billion and non-GAAP EPS of $3.35 both exceeded consensus estimates. Despite the headline beat, management's decision to raise full-year guidance only to roughly the midpoint of analyst expectations — rather than delivering a more aggressive upward revision — was interpreted as a signal of caution around second-half demand. Investors zeroed in on decelerating growth in the high-margin IP licensing business, which carries disproportionate weight in Synopsys' profitability profile. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
In early July, Reuters reported that Synopsys had informed over a dozen major semiconductor manufacturers — including Samsung Electronics, SK Hynix, Kioxia, and Qorvo — that it would discontinue a portfolio of legacy manufacturing process-control software products. While the company framed this as a strategic reallocation toward higher-margin AI-driven design tools, the announcement introduced near-term execution uncertainty and raised questions about potential revenue disruption.
A broad-based semiconductor selloff on July 17 compounded the pressure, with the Nasdaq falling 2.22% as investors rotated out of concentrated AI and technology positions. SNPS was caught in the downdraft, shedding nearly 8% in a single session. Insider selling also drew attention: CFO Shelagh Glaser sold shares at $450.02 on June 12, and CEO Sassine Ghazi sold shares at $458.96 on June 15, both under pre-arranged Rule 10b5-1 trading plans. While such sales are routine, they occurred at prices substantially above where the stock currently trades. Meanwhile, institutional activity was mixed — Dimensional Fund Advisors boosted its position by 28.1%, while Harel Insurance Investments cut its stake by 99.6%.
On the positive side, Benchmark initiated coverage with a Buy rating and a $570 price target on July 15, and Goldman Sachs highlighted Synopsys as a key beneficiary of the structural chip-design engineer shortage with a $600 price target. However, these bullish calls were insufficient to counter the overwhelming selling pressure.
The broader quarterly decline reflects a market that has grown more cautious about Synopsys' post-Ansys integration trajectory. While the acquisition substantially expanded the company's total addressable market and delivered eye-catching revenue growth of approximately 42% year-over-year, reported GAAP profitability has been compressed by integration costs, amortization of acquired intangibles, and deal-related charges. GAAP net income for Q2 was just $17.1 million, versus $349.2 million a year earlier, while GAAP EPS of $0.09 contrasted sharply with the non-GAAP figure of $3.35. This wide gap between GAAP and non-GAAP results has fueled debate about the true earnings power of the combined entity.
Additionally, management's commentary around "agentic AI" — AI systems that run Synopsys software alongside human engineers — signals a potentially transformative but unproven pricing model shift. CEO Sassine Ghazi described at the Mizuho Technology Conference a future where the company charges not just for human user subscriptions but for AI agent usage as well. While strategically compelling, this transition introduces complexity into revenue visibility at a time when investors are demanding clearer evidence that the Ansys deal will deliver the promised cross-selling synergies and margin expansion. The upcoming Investor Day on September 30 is widely expected to provide more clarity on these long-term targets.
Investors will be closely monitoring Synopsys' fiscal Q3 2026 earnings, expected in late August, for evidence that the IP licensing business is stabilizing and that full-year guidance can be revised materially higher. The company's September 30 Investor Day represents a critical catalyst, where management is expected to lay out long-term financial targets and elaborate on the AI-agent pricing model and Ansys synergy roadmap. Macroeconomic risks remain salient, including potential changes to U.S. export controls affecting China-exposed revenue (approximately 10% of total sales), geopolitical instability, and the trajectory of semiconductor R&D budgets in an environment of elevated trade tensions. On the competitive front, the duopoly with Cadence Design Systems remains stable, but the growing trend of hyperscale customers building custom chips in-house could reshape demand patterns over time. Technical traders will be watching whether deeply oversold RSI readings near 22 translate into a mean-reversion rally or whether structural concerns continue to drive price discovery lower.
During volatile stretches like this one for SNPS, I have found it helpful to review automated strategies for additional context. Tickeron’s Trending AI Robots page highlights top-performing bots with distinct strategies and performance metrics, offering a practical way to explore data-driven approaches that align with different investment objectives.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Disclaimers and LimitationsFinancial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The 10-day moving average for SNPS crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
SNPS moved above its 50-day moving average on October 26, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +7.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNPS advanced for three days, in 246 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
SNPS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 141 of 235 cases where SNPS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.
The 10-day RSI Indicator for SNPS moved out of overbought territory on October 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 21 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 60%.
The Momentum Indicator moved below the 0 level on October 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SNPS as a result. In 52 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
The Moving Average Convergence Divergence Histogram (MACD) for SNPS turned negative on October 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 29 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 63%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNPS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. SNPS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 64 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.795) is normal, around the industry mean (16.640). P/E Ratio (78.604) is within average values for comparable stocks, (60.382). Projected Growth (PEG Ratio) (2.237) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.213) among similar stocks. P/S Ratio (7.675) is also within normal values, averaging (103.889).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of software based designing solutions for the semiconductor industry
Industry ComputerCommunications